Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a Chemiluminescent Enzyme Immunoassay for the Detection of Prostaglandin E-Major Urinary Metabolite (PGE-MUM).

Journal of clinical laboratory analysis·2024
Same author

A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.

Hepatology research : the official journal of the Japan Society of Hepatology·2020
Same author

Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers.

Scientific reports·2020
Same author

Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.

Journal of clinical laboratory analysis·2017
Same author

Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.

Journal of gastroenterology·2016

Related Experiment Video

Updated: Mar 30, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.2K

[Development of Highly Sensitive Quantitative HBsAg Reagent and Its Availability].

Kazushige Moriyama, Mitsuo Isomura

    Rinsho Byori. the Japanese Journal of Clinical Pathology
    |November 4, 2015
    PubMed
    Summary

    A new highly sensitive assay for Hepatitis B surface antigen (HBsAg) improves detection in blood screening and patient monitoring. This advancement aids in managing Hepatitis B virus (HBV) infection and treatment efficacy.

    More Related Videos

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
    09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    14.1K
    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    2.8K

    Related Experiment Videos

    Last Updated: Mar 30, 2026

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
    04:11

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

    Published on: December 15, 2023

    5.2K
    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
    09:35

    Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

    Published on: February 1, 2017

    14.1K
    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    2.8K

    Area of Science:

    • Virology
    • Immunology
    • Clinical Chemistry

    Context:

    • Hepatitis B virus (HBV) surface antigen (HBsAg) is a key marker for HBV infection.
    • Blood screening for HBsAg in Japan began in 1972, with increased sensitivity in 2008.
    • Monitoring HBsAg levels is crucial for assessing treatment effectiveness and patient status.

    Purpose:

    • To develop a highly sensitive quantitative chemiluminescent enzyme immunoassay (HBsAg-HQ) for HBsAg detection.
    • To evaluate the diagnostic sensitivity and performance of the HBsAg-HQ reagent.
    • To compare the HBsAg-HQ reagent with existing immunoassay products.

    Summary:

    • The HBsAg-HQ reagent utilizes a pretreatment mixture and anti-HBs antibodies, achieving a low detection limit of 0.0006 IU/mL.
    • The assay demonstrated equal or superior diagnostic sensitivity compared to other immunoassay products in seroconversion panel testing.
    • HBsAg-HQ identified 25.8% of HBV patients as positive who were negative by other reagents, highlighting its enhanced detection capabilities.

    Impact:

    • The HBsAg-HQ assay improves the accuracy of blood screening, potentially reducing HBV transmission.
    • Enhanced HBsAg detection aids in monitoring the efficacy of nucleoside analogue treatments for chronic hepatitis B.
    • High-sensitivity HBsAg reagents are essential for assessing patients before immunosuppressive therapy and for confirming HBsAg seroclearance.